The global antibody drug conjugates market reached a value of USD 7.96 billion in 2024, driven by rising government awareness and growing recognition of the therapeutic potential of antibody drug conjugates worldwide. The market is projected to expand at a CAGR of 17.10% from 2025 to 2034, reaching approximately USD 38.59 billion by the end of the forecast period. https://www.expertmarketresearch.com/reports/antibody-drug-conjugates-market